# VIVACELLE BIO, INC.: Development of a phospholipid nanoparticle and small molecule-based combination drug for the treatment of lethal sepsis

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | VIVACELLE BIO, INC. |
| Location | Fort Wayne, IN |
| Project | Development of a phospholipid nanoparticle and small molecule-based combination drug for the treatment of lethal sepsis |
| Project number | 1R44GM165137-01 |
| Mechanism | R44 |
| Institute | National Institute of General Medical Sciences |
| Award | $690,878 |
| Awarded | 2026-09-11 |
| Project period | 2026-09-15 to 2028-08-31 |
| UEI | DFXZMMZ9BB21 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11404673). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.